Its crazy to sell at these prices- its undervalued by miles and is nearing a massive rerate with 5 x Phase 2 trials ( one already underway) slated for 2014 including its lead Oxy Pain product.
Stuart Roberts may not have got his target right when at Bells but on the back of the last OxyM trial results last month- its looking very achievable imho.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $15.30K | 3.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 17347504 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29054159 | 24 |
View Market Depth
| Last trade - 14.13pm 18/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |